(Q37686076)

22 August 2017

1 reference

title

Disease modification in ankylosing spondylitis (English)

1 reference

22 August 2017

Walter P Maksymowych

1

1 reference

PubMed ID

20125174

22 August 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

Nature Reviews Rheumatology

22 August 2017

1 reference

22 August 2017

6

1 reference

22 August 2017

2

1 reference

22 August 2017

75-81

1 reference

https://scigraph.springernature.com/pub.10.1038/nrrheum.2009.258

22 August 2017

0 references

cites work

Low molecular weight isoforms of the aggrecanases are responsible for the cytokine-induced proteolysis of aggrecan in a porcine chondrocyte culture system

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Long term evaluation of radiographic disease progression in a subset of patients with rheumatoid arthritis treated with leflunomide beyond 2 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Spondyloarthritis research consortium of canada magnetic resonance imaging index for assessment of spinal inflammation in ankylosing spondylitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Distinct topography of erosion and new bone formation in achilles tendon enthesitis: Implications for understanding the link between inflammation and bone formation in spondylarthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Contemporary concepts of inflammation, damage and repair in rheumatic diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Bone morphogenetic proteins in destructive and remodeling arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Dickkopf-1 is a master regulator of joint remodeling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

The relationship between inflammation and new bone formation in patients with ankylosing spondylitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: Evidence of a relationship between inflammation and new bone formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Inhibition of osteoclasts does not prevent joint ankylosis in a mouse model of spondyloarthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Expression of cathepsin K and matrix metalloproteinase 1 indicate persistent osteodestructive activity in long-standing ankylosing spondylitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Adalimumab is effective and well tolerated in treating patients with ankylosing spondylitis who have advanced spinal fusion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Development of a radiographic scoring tool for ankylosing spondylitis only based on bone formation: addition of the thoracic spine improves sensitivity to change

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: A multicenter, randomized, double-blind, placebo-controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

The natural course of radiographic progression in ankylosing spondylitis--evidence for major individual variations in a large proportion of patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

T(H)-17 cells in the circle of immunity and autoimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Association of interleukin-23 receptor variants with ankylosing spondylitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.258

Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis

31 March 2020

1 reference

12 December 2020

Th1/Th17 cytokine profiles in patients with reactive arthritis/undifferentiated spondyloarthropathy

1 reference

12 December 2020

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Beneficial effects of adalimumab on biomarkers reflecting structural damage in patients with ankylosing spondylitis

1 reference

12 December 2020

Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints.

1 reference

12 December 2020

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

1 reference

12 December 2020

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2009.258

1 reference

22 August 2017

1 reference

PubMed ID

20125174